Las Vegas, NV -- (SBWIRE) -- 12/09/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.EquityObserver.com issues a special report on the following stocks: SYSCO Corporation(NYSE:SYY), YRC Worldwide, Inc (NASDAQ:YRCW),Rosetta Genomics Ltd. (USA)(NASDAQ:ROSG), Alpha Natural Resources, Inc.(NYSE:ANR)
SYSCO Corporation(NYSE:SYY) increased 16.12% at the price of $39.38 recently on a traded volume of 26.49 million shares, in comparison to 3.22million shares of average trading volume. So far this year, the stock is up over 25.49%.
The company has a total market capitalization of $22.96 billion and its total outstanding shares are 3.22 million. Sysco Corporation (Sysco), along with its subsidiaries and divisions, is a North American distributor of food and related products primarily to the foodservice or food-away-from-home industry. The Company provides products and related services to approximately 425,000 customers, including restaurants, healthcare and educational facilities.
For How Long SYY will Fight for Profitability? Read This Trend Analysis report
YRC Worldwide, Inc (NASDAQ:YRCW) soared 14.56% at the trading price of $9.68 on a traded volume of 1.74 million shares till now, whereas its average trading volume is 1.17 million shares. In the last three months, the stock is down -45.84%. The Intra-day range for the stock is $9.05 and $10.50. YRC Worldwide Inc., through its subsidiaries, provides various transportation services primarily in North America. Its YRC Freight segment offers various services for the transportation of industrial, commercial, and retail goods, such as apparel, appliances, automotive parts, chemicals.
Is YRCW a Solid Investment at These Levels? Read This Report For Details
Rosetta Genomics Ltd. (USA)(NASDAQ:ROSG) jumped up 13.16% at the $3.42 recently. So far in three months, the stock is up 18.52%. The 52-week range for the stock is $3.30 and $3.59. Its introductory price for the day was $3.42, with the overall traded volume of 2.26 million shares. Rosetta Genomics Ltd., is seeking to develop and commercialize diagnostic tests based on discovered group of genes known as microRNAs. The Company has established a clinical laboratory improvement amendment (CLIA)-certified laboratory in Philadelphia, which enables it to develop, validate and commercialize its own diagnostic tests applying its microRNA technology. In July 2011, the Company launched its fifth product - miRview lung.
Will ROSG Continue To Move Higher? Find Out Here
Alpha Natural Resources, Inc.(NYSE:ANR), after opening its shares at the price of $6.81, jumped up 5.94% , its recent trading price was $6.96 for the day. The stock moved on a traded volume of 4.01 million shares, in comparison to 12.61 million shares of average trading volume.
The 52-week range for the stock is $4.78 and $10.74. Its introductory price for the day was $6.81. Alpha Natural Resources, Inc. (Alpha) is a supplier and exporter of metallurgical coals for use in the steel-making process and a supplier of thermal coal to electric utilities and manufacturing industries, as well as a exporter of thermal coal. As of December 31, 2012, the Company operated 107 mines and 26 coal preparation plants in Northern and Central Appalachia and the Powder River Basin.
Why Should Investors Buy ANR After The Recent Gain? Just Go Here and Find Out
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/ employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/disclaimer-2/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)